Cargando…

Combined ablation for paroxysmal atrial fibrillation and drug-refractory hypertrophic obstructive cardiomyopathy: a case report

BACKGROUND: Hypertrophic obstructive cardiomyopathy (HOCM) is sometimes concomitant with atrial fibrillation (AF) and exacerbates heart failure symptoms. Although optimal medication for the reduction of left ventricular outflow tract (LVOT) obstruction and the maintenance of sinus rhythm should be c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akita, Keitaro, Suwa, Kenichiro, Urushida, Tsuyoshi, Maekawa, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898580/ https://www.ncbi.nlm.nih.gov/pubmed/33644658 http://dx.doi.org/10.1093/ehjcr/ytaa570

Ejemplares similares

Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study
por: Suwa, Kenichiro, et al.
Publicado: (2021)

Pseudothrombotic appearance on pulmonary valve by intracardiac echocardiography during atrial fibrillation ablation
por: Sano, Makoto, et al.
Publicado: (2020)

Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2018)

Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation
por: Ikoma, Takenori, et al.
Publicado: (2022)

Significant reduction of left atrial volume concomitant with clinical improvement after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection with multidetector CT
por: Maekawa, Yuichiro, et al.
Publicado: (2016)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Gallen, Rory, et al.
Publicado: (2021)

Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report
por: Fang, Dingfeng, et al.
Publicado: (2022)

Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy
por: Komatsu, Junya, et al.
Publicado: (2021)

Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series
por: Maagh, Petra, et al.
Publicado: (2016)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Cryoballoon Ablation for Patients With Paroxysmal Atrial Fibrillation
por: Suenari, Kazuyoshi, et al.
Publicado: (2020)

Drug-refractory Heart Failure in Female Carrier of Duchenne Muscular Dystrophy: A Case of X-linked Dilated Cardiomyopathy
por: Ohtani, Hayato, et al.
Publicado: (2022)

The association between the clinical severity of heart failure and docosahexaenoic acid accumulation in hypertrophic cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2022)

Radiofrequency catheter ablation for drug-refractory paroxysmal atrial fibrillation in a patient with Ebstein’s anomaly
por: Kim, Yong-Giun, et al.
Publicado: (2016)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
por: Ikenaga, Hiroki, et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

An Unusual Presentation of Paroxysmal Atrial Fibrillation Following Ablation
por: Kerosky, Zachary P, et al.
Publicado: (2022)

Prevalence and Characteristics of Inspiration-Induced Negative Left Atrial Pressure during Pulmonary Vein Isolation
por: Ikoma, Takenori, et al.
Publicado: (2023)

Cryoballoon ablation of the left atrial posterior wall reduces recurrence of persistent atrial fibrillation in patients with non‐paroxysmal atrial fibrillation
por: Shigeta, Takatoshi, et al.
Publicado: (2021)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Liu, Li-Min, et al.
Publicado: (2020)

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2022)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Gastro-Esophageal Reflux Disease and Paroxysmal Atrial Fibrillation Ablation
por: Floria, Mariana, et al.
Publicado: (2023)

The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation
por: Wang, Xule, et al.
Publicado: (2020)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome
por: Dinshaw, Leon, et al.
Publicado: (2021)

Association Between TCF21 Gene Polymorphism with the Incidence of Paroxysmal Atrial Fibrillation and the Efficacy of Radiofrequency Ablation for Patients with Paroxysmal Atrial Fibrillation
por: Zhang, Xianlin, et al.
Publicado: (2022)

Delayed cardiac tamponade in catheter ablation for paroxysmal atrial fibrillation induced by a subacute hemorrhage
por: Ishiguchi, Hironori, et al.
Publicado: (2020)

Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Bougioukas, Ioannis, et al.
Publicado: (2016)

Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
por: Rigopoulos, Angelos G., et al.
Publicado: (2016)

Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy
por: Aksu, Tolga, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7mbk5l9jp0m9gmavvrit1g6jn3